Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

LifePath Remote Patient Monitoring Platform

K-Number: K211822 · 2022-02-03

Decision Date2022-02-03
Product CodeDRG
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

LifePath Remote Patient Monitoring Platform is a medical device manufactured by Elastic Care Incorporated. It received FDA 510(k) clearance on 2022-02-03 under approval number K211822. The device is classified under product code DRG. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the LifePath Remote Patient Monitoring Platform?

LifePath Remote Patient Monitoring Platform is a medical device that received FDA 510(k) clearance on 2022-02-03. It is manufactured by Elastic Care Incorporated. The 510(k) number is K211822.

When was LifePath Remote Patient Monitoring Platform approved by the FDA?

LifePath Remote Patient Monitoring Platform received FDA 510(k) clearance on 2022-02-03, under approval number K211822.

What company makes LifePath Remote Patient Monitoring Platform?

LifePath Remote Patient Monitoring Platform is manufactured by Elastic Care Incorporated.

What is the FDA product code for LifePath Remote Patient Monitoring Platform?

The FDA product code for LifePath Remote Patient Monitoring Platform is DRG.

Related Clinical Trials

Related PubMed Literature

Related Devices (Code: DRG)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.